BMS’ Sprycel Is Latest CDF Drug To Get NICE Clearance For Routine NHS Use

 
• By Ian Schofield
  
SC1606_Funding_1200
NICE is moving products from the Cancer Drugs Fund to NHS Commissioning
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access